These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 27514846

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Microenvironmental interactions in chronic lymphocytic leukemia: the master role of CD49d.
    Dal Bo M, Tissino E, Benedetti D, Caldana C, Bomben R, Del Poeta G, Gaidano G, Rossi FM, Zucchetto A, Gattei V.
    Semin Hematol; 2014 Jul; 51(3):168-76. PubMed ID: 25048781
    [Abstract] [Full Text] [Related]

  • 3. Methods for Investigating VLA-4 (CD49d/CD29) Expression and Activation in Chronic Lymphocytic Leukemia and Its Clinical Applications.
    Zucchetto A, Tissino E, Chigaev A, Hartmann TN, Gattei V.
    Methods Mol Biol; 2019 Jul; 1881():101-112. PubMed ID: 30350200
    [Abstract] [Full Text] [Related]

  • 4. The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.
    Brachtl G, Piñón Hofbauer J, Greil R, Hartmann TN.
    Ann Hematol; 2014 Mar; 93(3):361-74. PubMed ID: 24288111
    [Abstract] [Full Text] [Related]

  • 5. The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells.
    Zucchetto A, Vaisitti T, Benedetti D, Tissino E, Bertagnolo V, Rossi D, Bomben R, Dal Bo M, Del Principe MI, Gorgone A, Pozzato G, Gaidano G, Del Poeta G, Malavasi F, Deaglio S, Gattei V.
    Leukemia; 2012 Jun; 26(6):1301-12. PubMed ID: 22289918
    [Abstract] [Full Text] [Related]

  • 6. CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism.
    Zucchetto A, Caldana C, Benedetti D, Tissino E, Rossi FM, Hutterer E, Pozzo F, Bomben R, Dal Bo M, D'Arena G, Zaja F, Pozzato G, Di Raimondo F, Hartmann TN, Rossi D, Gaidano G, Del Poeta G, Gattei V.
    Blood; 2013 Nov 07; 122(19):3317-21. PubMed ID: 24068493
    [Abstract] [Full Text] [Related]

  • 7. CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL.
    Majid A, Lin TT, Best G, Fishlock K, Hewamana S, Pratt G, Yallop D, Buggins AG, Wagner S, Kennedy BJ, Miall F, Hills R, Devereux S, Oscier DG, Dyer MJ, Fegan C, Pepper C.
    Leuk Res; 2011 Jun 07; 35(6):750-6. PubMed ID: 21093051
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In contrast to high CD49d, low CXCR4 expression indicates the dependency of chronic lymphocytic leukemia (CLL) cells on the microenvironment.
    Kriston C, Plander M, Márk Á, Sebestyén A, Bugyik E, Matolcsy A, Barna G.
    Ann Hematol; 2018 Nov 07; 97(11):2145-2152. PubMed ID: 29955944
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.
    Zucchetto A, Benedetti D, Tripodo C, Bomben R, Dal Bo M, Marconi D, Bossi F, Lorenzon D, Degan M, Rossi FM, Rossi D, Bulian P, Franco V, Del Poeta G, Deaglio S, Gaidano G, Tedesco F, Malavasi F, Gattei V.
    Cancer Res; 2009 May 01; 69(9):4001-9. PubMed ID: 19383907
    [Abstract] [Full Text] [Related]

  • 13. Microenvironmental interactions in chronic lymphocytic leukemia: hints for pathogenesis and identification of targets for rational therapy.
    Dal Bo M, Bomben R, Zucchetto A, Del Poeta G, Gaidano G, Deaglio S, Efremov DG, Gattei V.
    Curr Pharm Des; 2012 May 01; 18(23):3323-34. PubMed ID: 22591383
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages.
    Eksioğlu-Demiralp E, Alpdoğan O, Aktan M, Firatli T, Oztürk A, Budak T, Bayik M, Akoğlu T.
    Leukemia; 1996 Aug 01; 10(8):1331-9. PubMed ID: 8709639
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.